Nuvation Bio NUVB
NYSE NUVB
$4.86 +0.09 (+1.89%)
As of: Oct 21, 2026 · 3:59 PM EDT

Nuvation Bio (NUVB) Receivables (2024 - 2026)

Updated

Nuvation Bio (NUVB) recorded Receivables of $27.83 million in Q2 2026, up 933.3% from $2.69 million a year earlier and up 22.5% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Receivables (2024 - 2026) Analysis & Trends

At the end of FY2025, Nuvation Bio reported Receivables of $16.08 million, up 26.4% from FY2024.

  • Across earlier years, Receivables came in at $12.72 million in FY2024.
  • The Q2 2026 figure is the highest quarterly Receivables in data going back to Q2 2024.
  • Per Business Quant, the preceding three quarters came in at $22.72 million (Q1 2026), $16.08 million (Q4 2025) and $8.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Nuvation Bio 1.70 Bn -576.18 Mn - 27.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.83 Mn
Mar 31, 2026 22.72 Mn
Dec 31, 2025 16.08 Mn
Sep 30, 2025 8.32 Mn
Jun 30, 2025 2.69 Mn
Mar 31, 2025 409,000.00
Dec 31, 2024 12.72 Mn
Sep 30, 2024 112,000.00
Jun 30, 2024 117,000.00
API Access

Nuvation Bio Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NUVB&period=max&api_key=YOUR_API_KEY